Nabi HB®

Nabi-HB®, Hepatitis B Immune Globulin (Human), is indicated for treatment of acute exposure to blood containing HBsAg, perinatal exposure of infants born to HBsAg-positive mothers, sexual exposure to HBsAg-positive persons and household exposure to persons with acute HBV infection in the following settings when the conditions described in the PI are met:?

- Acute Exposure to Blood Containing HBsAg
- Perinatal Exposure of Infants Born to HBsAg-positive Mothers
- Sexual Exposure to HBsAg-positive Persons
- Household Exposure to Persons with Acute HBV Infection

Nabi-HB® is indicated for intramuscular use only.

For indications, dosing and other information, please refer to the prescribing information.

Nabi HB® ‐ ADMA Biologics

Size:
1 mL SDV
NDC #:
59730-4202-01
Download:
PI
Size:
5 mL SDV
NDC #:
59730-4203-01
Download:
PI